2025 Conference: Regenerative and Longevity Medicine (self study) Price: $275.00 Status: Available
Regenerative and Longevity Medicine
Join us for an inspiring and dynamic gathering of healthcare professionals at this year’s Annual Naturopathic Doctor Conference, where the theme is Longevity and Regenerative Medicine. Dive into cutting-edge research, innovative therapies, and practical insights designed to transform your practice and help your patients thrive with optimal health and vitality.
This year’s program highlights exciting advancements, including the regenerative potential of adipose tissue for musculoskeletal (MSK) conditions, breakthroughs in mitochondrial health, and the science of enhancing autophagy to reduce disease risk. Explore topics ranging from the use of microfragmented adipose tissue (MFAT) to repair tendons and ligaments to strategies for extending brain health and lifespan.
Gain practical tools to identify ideal candidates for regenerative therapies, stay ahead of the curve with personalized hormone protocols, and decode genetic markers that influence cellular health. Whether you’re passionate about the transformative power of regenerative medicine, intrigued by the mechanisms behind aging, or eager to integrate evidence-based longevity practices, this conference offers everything you need to advance your expertise.
Connect with thought leaders in naturopathic medicine and collaborate with colleagues who share your commitment to advancing healthspan and longevity. With expert-led sessions on emerging therapies like GLP-1 medications, senolytic compounds, and advanced regenerative injections, this is your chance to elevate your knowledge and make a lasting impact. Reserve your spot today and take the next step in shaping the future of healthcare!
---
Peter Koshland Pharm.D
PART 1
GLP-1s – Great Hope or Great Hype
No medications in history have captured America’s attention more than the GLP-1s. Drugs like semaglutide and terzepatide (brand names Ozempic, Wegovy and Zepbound) have become household names. But are these drugs just the latest in a wave of weight loss gimmicks or is there real science to back up the hype? We will dive into these questions, looking at the extensive research with these drugs for weight loss as well as a myriad of other conditions. We will discuss how these drugs work as well as what are appropriate prescribing and monitoring protocols for these therapies.
Goals and Objectives:
1. Review the glucagon/insulin system
2. Understand the role of GLP-1 receptors in satiety and glucose regulation
3. Learn the pharmacokinetics and pharmacodynamics of the GLP-1 drugs
4. Review the latest research on GLP-1s for weight loss, cardiovascular health, brain health, and more
5. Understand the regulatory environment surrounding the GLP-1s and accessibility issues surrounding these drugs
6. Learn how to identify patients who are appropriate candidates for these drugs, how to appropriately prescribe the GLP-1 drugs, and how to monitor the therapy effectively
Biography:
Peter Koshland, PharmD, is a graduate of Georgetown University (Chemistry BS) and the University of California at San Francisco School of Pharmacy (PharmD). He has served as an Adjunct Clinical Professor of Pharmacy at UCSF since 2010.
Peter opened his compounding pharmacy, Koshland Pharm, in 2009 in San Francisco. He and his staff work with doctors and patients on individualized compounded therapies that make a difference in the quality of patients’ day-to-day lives. Koshland Pharm is the only compounding pharmacy in San Francisco accredited by the Pharmacy Compounding Accreditation Board because of its commitment to quality. In addition to leading Koshland Pharm, Peter trains and consults with doctors across the state of California in the areas of hormone replacement, thyroid disorders, and compounding applications for dermatology, urology, pain management, and psychiatry. He was invited to speak at the National Academies of Sciences, Engineering and Medicine in 2019. He is a current Board Member and Fellow of the Alliance for Pharmacy Compounding, a national organization representing pharmacists in both 503A and 503B pharmacies.
Penny Kendall-Reed, ND
PART 1 Enhancing Autophagy through genetics: why individual rates vary and how to alter them to minimize disease risk.
Autophagy, literally meaning “self-devouring”, is the body’s natural self-preservation mechanism for removing damaged or dysfunctional components within cells and recycling them for cellular repair. If this process is inadequate or inefficient, a build-up of damaged material within the cell not only impairs its function but has the ability to catalyse disease processes. For this reason, autophagy has been the focus of much medical research over the past few years and plays a major role in the prevention and treatment of many diseases such as cancer, Alzheimer’s, inflammatory bowel disease, diabetes and aging.
Autophagy is naturally stimulated by fasting. Without sufficient nutrients, particularly protein, the body starts to break down and recycle damaged cells to provide the protein and other materials to repair healthy tissues. This occurs through the simultaneous modification of several genetically controlled pathways. Inhibition of mTOR and PI3K pathways results in a slowing of cellular growth and differentiation, while an increase in the production of SIRT6, Beclin1 and AG16L1 (Autophagy-Related 16L1 protein) directly stimulates autophagy.
We know that rates of autophagy vary greatly between individuals, putting some at increased risk of disease and aging. We also know that traditional fasting diets allow some people to move into and maintain autophagy quite easily within 2 to 3 days, while others take 5 days or more and require a more rigorous fasting regimen and additional supplements to achieve the same results. But how, as a health practitioner can we distinguish between them? And how do we know how strong their autophagy pathways are? The answers lie in our genetics! For example, our genes dictate how much Beclin1, SIRT6 and ATG16L1 we make and to what degree other variables such as stress and inflammation block naturally occurring pathways.
In this lecture you will learn the key principles behind autophagy, the unique SNPs that make an individual more susceptible to lower autophagy rates, and how to treat those SNPs using diet, exercise and natural supplementation.
Goals and Objectives:
After the presentation, participants will be able to confidently:
Learn the 3 main types of autophagy, and the cellular mechanisms behind them.
Learn why and how autophagy is at the corner stone of most aging processes and diseases.
Learn why the rates of autophagy vary from person to person and why that leaves people at a much higher risk of developing serious diseases such as cancer and diabetes.
Learn which SNPs are involved in autophagy and how to treat them with diet, natural supplementation and exercise to maximize autophagy and minimize disease development.
Review comparative case studies demonstrating these processes.
---
PART 2
Moving through Menopause/ Perimenopause: Why We Need to Rethink Our Treatment
All women transition through menopause, but their experience of timing, symptoms and duration is unique. Not every female suffers from hot flashes, insomnia, or weight gain; some women experience no adverse effects whatsoever. So why are we still treating symptoms with the same “cookie -cutter” treatment even before we know which, if any, will occur? And what if, by instituting traditional therapies like estrogen and progesterone, we are actually increasing the risk of serious disease? Considering this, perhaps it is time for a new approach to menopause management. One that is measured and personalized. Menopause is the result of lower estradiol and inhibin from fatigued ovarian granulosa cells. However, it is the resulting disruption in the HPA axis that leads to the failure of endometrial development. Subsequently, both the HPA and the HPG axis’s lose sensitivity to feedback from estrogen. Giving more estrogen to a system that is already desensitized is not the answer.
Other important changes occur at menopause outside of a reduction in estrogen, and recent research indicates that these should be key areas of focus. For instance, an increase in neurokinin-B and kisspeptin is the main cause of daytime hot flashes, while increased cortisol results in mood disorders, insomnia and weight gain and nighttime hot flashes and sweats.
In this lecture I will explain the various metabolic and physiological changes that occur at menopause, and review recent research into the causes of menopausal symptoms. I will discuss the key genetic SNPs to consider when treating individual menopausal patients, not only to see which symptoms are most likely to arise, but moreover, what is the safest and most effective way of treating them. I will discuss why very few women actually need to use estrogen, and when they do, how we can improve its safety profile.
Goals and Objectives:
After the presentation, participants will be able to confidently:
Discover the newer and more potent physiological changes that occur at menopause outside of estrogen.
Review non-estrogenic pharmacological treatments for menopause.
Learn which SNPs are crucial when treating menopausal symptoms, especially if estrogen in any form (natural, bio-identical or pharmaceutical) is to be used.
Learn how to effectively and safely treat menopausal symptoms using natural supplementation on a highly individual and personalized basis.
Put it all together with comparative case studies.
Biography
Dr. Penny Kendall-Reed, N.D., is a naturopathic doctor in Toronto. After graduating from McGill University in Neurobiology, she earned a degree in Naturopathic Medicine from the Canadian College of Naturopathic Medicine, where she received the Dr. Allen Tyler Award for Most Outstanding Clinician. Dr. Kendall-Reed is the author of six national best-selling books, including the most recently released book, “Fix Your Genes to Fit Your Jeans,” which she co-authored with her husband, Dr. Stephen Reed. She was voted Naturopath of the Year in 2013, and in 2018 received the “Top Naturopathic Doctor” award in Canada. Dr. Kendall- Reed is the creator of the integrated genetic platform GeneRx.ca. She analyzes and interprets genetic profiles to design personalized health programs for patients worldwide. She is a medical consultant for Pure Encapsulations® and Douglas Laboratories®, is on the board of Pure Genomics and is the medical director of Natural Therapies at The Urban Wellness PKRHealth Clinic.
Paul S. Anderson, NMD
PART 1 Mitochondrial Health and Regeneration - Longevity
The role of potent mitochondrial repair agents including Methylene Blue, NAD, Photodynamic Therapy and other mitochondrial primers. While most of us focus on mitochondrial therapies, newer avenues using supplements and or drugs to support mitochondrial function are readily available. In this session Dr. Anderson will break down the pharmacology and clinical applications of these agents.
Goals and Objectives:
1. Describe the mechanics of mitochondrial activity / OxPhos
2. Define the potential weak points of the mitochondria due to chronic illness
3. Define the potential weak points of the mitochondria due to drugs
4. Define the potential weak points of the mitochondria due to toxicity
---
PART 2
Mitochondrial Health and Regeneration – Longevity Part 2
Mitochondrial function is shaped by key factors essential for energy production and cellular repair. Nutrients like B vitamins, magnesium, and coenzyme Q10 fuel the electron transport chain, while NAD drives energy transfer and mitochondrial biogenesis. Thyroid hormones boost oxygen use and ATP production, optimizing metabolism, and Methylene Blue enhances ATP generation by bypassing damaged respiratory chain complexes. Photodynamic therapy adds a non-invasive approach, using targeted light to amplify energy output, reduce inflammation, and promote repair. In this session, Dr. Anderson will unpack the pharmacology and clinical applications of these powerful mitochondrial therapies.
Goals and Objectives
1. Describe the effect of nutrients on mitochondrial function
2. Describe the effect of NAD on mitochondrial function
3. Describe the effect of Thyroid on mitochondrial function
4. Describe the effect of Methylene Blue on mitochondrial function
5. Describe the effect of Photodynamic Therapy on mitochondrial function
Brief Biography:
Dr. Anderson is a recognized educator and clinician in integrative and naturopathic medicine with a focus on complex chronic illness, and cancer. In addition to three decades clinical experience, he also was head of the interventional arm of a US-NIH funded human research trial using IV and integrative therapies in cancer patients. He founded Advanced Medical Therapies in Seattle, Washington, a clinic focusing on cancer and chronic diseases and now focuses his time in collaboration with clinics and hospitals in the US and other countries.
Former positions include multiple medical school posts, Professor of Pharmacology and Clinical Medicine at Bastyr University and Chief of IV Services for Bastyr Oncology Research Center.
He is co-author of the Hay House book “Outside the Box Cancer Therapies” with Dr. Mark Stengler, and the Lioncrest Publishing book “Cancer… The Journey from Diagnosis to Empowerment.”. He is also co-author with Dr.’s Osborne and Carter of the IV textbook “A Scientific Reference for Intravenous Nutrient Therapy”.
Mai Tran, PharmD
PART 1 Physiologic Hormone Restoration Therapy: A Novel Hormonal Approach to Longevity
In the past decade, both healthcare providers and patients have gradually begun to recognize hormone replacement therapy (HRT) as a cornerstone treatment for women during the perimenopausal and menopausal phases. Nonetheless, concerns regarding the use of estrogen persist, primarily stemming from misleading assertions linking it to an increased risk of breast cancer. Consequently, many providers remain entrenched in the traditional belief that the lowest possible doses of estrogen should be administered to alleviate menopausal symptoms.
Research examining the reproductive levels of estradiol and progesterone throughout the menstrual cycle has demonstrated significant benefits related to the maintenance of bone health, breast health, cardiovascular health, and more. However, the current doses of estrogen and progesterone utilized in HRT fall substantially short of the levels observed in reproductive, premenopausal women.
Physiologic Hormone Restoration Therapy (PHRT) represents a form of rhythmic HRT that aims to restore the physiological levels of estradiol and progesterone in perimenopausal and menopausal women. This approach can assist women experiencing hormone deficiencies reverse osteoporosis, mitigate cardiovascular disease, and protect their breast health.
In this presentation, the current utilization of HRT and the limitations associated with the low-dose estrogen approach will be discussed. Attendees will learn about the advantages of maintaining reproductive hormone levels akin to those found in premenopausal women and how Physiologic HRT can facilitate these benefits for perimenopausal and menopausal women. Additionally, attendees will be introduced to the administration and management of Physiologic HRT in perimenopausal/menopausal population and will be provided with actionable strategies for implementation should they choose to initiate Physiologic HRT for their patients.
Goals and Objectives
1. Demonstrate the disadvantages of utilizing a low-dose approach for HRT
2. Recognize the physiologic levels of estradiol and progesterone throughout a menstrual cycle in a premenopausal woman
3. Identify the advantages of having physiologic, premenopausal levels of estradiol and progesterone in perimenopausal and menopausal women
4. Describe how premenopausal levels of estradiol and progesterone can be implemented in the Physiologic Hormone Restoration Therapy system.
---
PART 2
The Oxytocin Experience
When the hormone oxytocin is mentioned, it is often associated primarily with its role in facilitating uterine contractions during childbirth. However, its applications extend far beyond the labor and delivery setting. The body of clinical research supporting the use of oxytocin for various conditions has expanded significantly, owing to its ease of accessibility, substantial efficacy, and favorable side effect profile.
In this presentation, attendees will explore how clinical studies have validated the use of oxytocin in treating conditions such as social anxiety disorder, post-traumatic stress disorder (PTSD), sexual health issues in both men and women, dyspareunia, migraines, binge eating disorders, and pain management, among others. A review of the various dosage forms and their respective advantages and disadvantages will be discussed. Attendees will be educated on the clinically studied doses and their specific indications, as well as anticipated side effects and the recommended dose adjustments to mitigate them.
Goals and Objectives
1. Discuss the benefits of oxytocin in its use for sexual health in both men and women, anxiety, PTSD, migraines, and vaginal atrophy.
2. Identify the different formulations of oxytocin available.
3. Discuss the various indications for oxytocin based on clinical studies
4. Identify the proper doses and routes of administration of oxytocin for specific indications.
Brief Biography:
Mai is a compounding pharmacist and the Director of Sales, Marketing, and Clinical Education at Harbor Compounding Pharmacy. She earned her Doctorate of Pharmacy from the University of the Pacific Thomas J. Long School of Pharmacy and has over a decade of experience at Harbor. In her role, Mai works closely with physicians and patients to identify gaps in traditional treatments and collaborates with Harbor’s compounding team to develop innovative, personalized formulations that address specific medical needs.
In 2020, Mai launched Harbor Academy, where she has personally trained over 100 healthcare providers on dosing and management strategies for bioidentical hormone replacement therapy (HRT) and other compounded formulations, with the goal of optimizing patient outcomes.
Mai has a strong passion for advancing women’s health. She has contributed to the development of oxytocin formulations at Harbor Compounding and collaborates with the Clinical Advisory Team at the Women’s Hormone Network, working to educate healthcare providers about Physiological Hormone Restoration Therapy (PHRT).
Her extensive experience in hormone therapy and women’s health makes her a valuable resource for healthcare professionals across the country who are seeking to expand their knowledge in these areas.
John Neustadt, ND
PART 1 Osteoporosis Pharmaceutical Management
The FDA has approved more than a dozen osteoporosis medications. Understanding these medications' potential benefits and risks is crucial when advising patients and answering
their questions. In this talk, Dr. Neustadt reviews the medications, teaches clinicians which ones are best for primary and secondary fracture prevention, and discusses how clinicians can discuss these drugs with patients to help them make the best decisions for their health.
Goals and Objectives
1. Understand which medications are best for primary versus secondary fracture prevention
2. Understand the safety profiles of the medications
3. Learn about medication compliance and the number needed to treat to prevent fractures
4. Feel comfortable answering patients’ questions about the medications
---
PART 2 Clarifying the Vitamin K Confusion
Naturally occurring Vitamin K is a group of lipid-soluble, essential nutrients that includes vitamins K1 and K2. In recent decades, basic and clinical research have demonstrated Vitamin K’s wide-ranging benefits beyond its role in coagulation. However, the different vitamin K moieties are different molecules with distinct physiological impacts. Complicating our understanding is that there are fifteen subtypes of vitamin K2, and published research frequently doesn’t define the vitamin K2 moiety being studied. Additionally, to date, 15 vitamin K-dependent enzymes have been identified, but not all forms of vitamin K have been shown to equally activate these enzymes and improve clinical outcomes. This presentation reviews vitamin K’s clinical applications for cardiovascular disease, osteoporosis, and cancer and its potential emerging role in neurological health. Controversies around vitamin K will also be addressed, including a 2021 study that concluded dietary vitamin K2 is associated with increased breast cancer mortality.
Goals and Objectives
1. Understand the differences between forms of Vitamin K and where they’re found
2. Understand which forms of vitamin K have been shown to improve clinical outcomes.
3. Be able to read and understand the vitamin K research more easily.
4. Be able to explain to patients why you may prescribe one form of vitamin K over another. .
Brief Biography
John Neustadt, ND, is the Founder and President of the dietary supplement company Nutritional Biochemistry, Inc. (NBI, nbihealth.com) and NBI Pharmaceuticals. Dr. Neustadt started NBI in 2006 when he couldn’t find products with the doses or combinations of nutrients shown in clinical trials to work, and he needed to help his patients.
Dr. Neustadt received multiple US FDA Orphan Drug Designations for potentially treating rare diseases using natural products. He hosts the Delivering Health podcast, is a member of the Bone Health and Osteoporosis Foundation (BHOF) Corporate Advisory Roundtable (CAR), and is Vice President and Treasurer of the California Naturopathic Doctors Association (CNDA).
Dr. Neustadt has written four books, dozens of articles on osteoporosis, and over 100 published research reviews. Elsevier recognized him as a Top Ten Cited Author in the world for his work. His latest book is Fracture-Proof Your Bones: A Comprehensive Guide to Osteoporosis
Name: Jacob Leone, ND
PART 1 Extending Lifespan: A Clinical Framework for Evidence-Based Longevity Medicine in Daily Practice –
Longevity medicine is an exciting and rapidly evolving field poised to revolutionize healthcare and significantly impact humanity. However, its novelty can make it challenging for clinicians to incorporate into daily practice. This presentation offers a practical framework for integrating longevity medicine into clinical care, emphasizing evidence-based strategies rooted in the principles of Naturopathic Medicine. Participants will explore interventions supported by human data that demonstrate mortality reduction, including preventive screenings, diet, lifestyle changes, environmental exposure management, and psychosocial factors. The session provides actionable insights to help clinicians promote longevity and improve patient outcomes.
Goals and Objectives
1. Implement evidence-based strategies for promoting longevity in your patients
2. Understand how preventative screenings and health maintenance measures reduce mortality
3. Understand which diets have the most data for reducing mortality
---
PART 2 Extending Lifespan: A Clinical Framework for Evidence-Based Longevity Medicine in Daily Practice – Part 2
Building on the foundation of longevity medicine, this session delves deeper into the lifestyle and environmental factors that influence mortality risk. Clinicians will learn how to identify and mitigate the impacts of environmental exposures, apply interventions to address psychosocial determinants, and adopt emerging strategies for lifespan extension. From practical lifestyle adjustments to cutting-edge advancements, this presentation equips healthcare providers with the knowledge and tools to implement effective longevity-focused care in their practice.
Goals and Objectives
1. Understand what lifestyle factors influence mortality risk
2. Understand how environmental exposures affect mortality risk and interventions for mitigating risk
3. Understand emerging strategies for increasing lifespan
Brief Biography
Dr. Jacob Leone ND is founder of a successful private healthcare practice and maintains an active license in multiple states. He has 17 years of experience practicing as an integrative primary care doctor with a specialty focus in complex chronic disease and longevity medicine. Dr Leone is passionate about education and lectures at national medical conferences, community clinics, and medical schools. He has been involved in several research studies over the past 3 decades investigating a wide range of topics including Long COVID, Lyme Disease, Bartonellosis, Babesiosis, HCV, HIV, and mental health. He is an active member of several professional organizations including the California Naturopathic Doctors Association (CNDA), American Association of Naturopathic Physicians (AANP), and the International Lyme Disease Society (ILADS).
Name: Clement Lee, NMD
PART 1 Optimized Regenerative Injection Therapies: A Comprehensive Approach
Regenerative injection therapies represent a promising subset of regenerative medicine, aimed at stimulating the body's natural healing processes to repair damaged tissues. These minimally invasive treatments include platelet-rich plasma (PRP), biologics, and prolotherapy/prolozone. Despite growing clinical interest, optimizing these therapies for consistent and effective outcomes remains a challenge.
This presentation will explore advanced strategies to enhance the efficacy of regenerative injection therapies. We will discuss recent developments in preparation techniques, delivery methods, and combination approaches that show potential for improving therapeutic results. The focus will be on optimizing treatments for musculoskeletal conditions, sports injuries, and degenerative joint diseases. Integration of supportive therapies such as peptides, supplements, and photobiomodulation and photodynamic therapies show to enhance the effectiveness of the treatment modalities
Goals and Objectives
1. Understand the principles and current limitations of regenerative injection therapies
2. Explore innovative techniques for optimizing PRP and stem cell preparations
3. Examine the role of peptides and laser therapy in enhancing regenerative outcomes
4. Discuss the potential of combination therapies and targeted delivery systems
5. Review clinical evidence and case studies demonstrating successful optimization strategies
---
PART 2 A Comprehensive Approach to Longevity: Identifying Hidden Threats and Leveraging Cutting-Edge Interventions
The pursuit of longevity extends beyond traditional health maintenance, requiring a multifaceted approach that addresses both obvious and hidden factors affecting lifespan and healthspan. This presentation outlines a comprehensive strategy for optimizing longevity, focusing on identifying and mitigating sources of chronic inflammation while leveraging innovative interventions.
We will explore how environmental toxins, including heavy metals, synthetic chemicals, and mycotoxins, as well as occult infections, contribute to systemic inflammation and accelerated aging. The discussion will then shift to cutting-edge interventions designed to counteract these effects and promote cellular health and longevity.
Our approach integrates advanced diagnostics with a broad spectrum of therapeutic modalities, including peptide therapies, targeted nutraceuticals, lifestyle modifications, repurposed medications, and novel treatments such as photodynamic therapy. By combining these strategies, we aim to create a synergistic effect that addresses the root causes of premature aging while enhancing the body's natural regenerative capabilities.
Goals and Objectives
1. Understand the impact of environmental toxins and hidden infections on longevity
2. Explore advanced diagnostic techniques for identifying sources of chronic inflammation
3. Examine the potential of peptide therapies in promoting cellular health and longevity
4. Discuss the role of nutraceuticals and repurposed medications in age management
5. Review emerging technologies like photodynamic therapy in longevity medicine
6. Integrate lifestyle modifications with advanced interventions for optimal results
Brief Biography
Dr. Clement Lee is the founder of Optimal Health & Wellness, a comprehensive care clinic in Pasadena, California. He created this integrative wellness approach to offer the best care possible to his patients.
Dr. Lee is an expert in regenerative medicine and injection therapies as well as treating chronic illness including lyme, mold, parasites, hidden infections, environmental toxicities, and more. Dr. Lee has been an early adopter of various advanced IV therapy techniques such as vitamins, botanicals, peptides, ozone, IV laser and photodynamic therapy. Dr. Lee is constantly innovating, combining and adapting with the latest advancements in health care, chronic illnesses, anti-aging, longevity, regenerative medicine, and integrative care modalities. He is always trying to improve the quality of care for his patients and to help them look to the true underlying sources of their illnesses to help them achieve their full optimal potential. Even the healthiest of individuals still may need evaluation and treatment of some of the underlying issues to maintain their dynamic health for the long run. Dr. Lee is personally experimenting himself with all the different modalities, practically everything he recommends he has tried himself personally in his attempt to achieve optimal health
Alice Nguyen, ND
PART 1 Exercise and Longevity: Muscle as the Cornerstone of Healthspan
This course explores the foundational role muscle plays in enhancing healthspan, with a focus on its impact on longevity and resilience against all-cause mortality. Led by Dr. Alice Nguyen, Director of Naturopathic Medicine at Stark Health, the course integrates evidenced-informed approaches with practical assessment and intervention strategies.
Goals and Objectives
1. Understand the key consequences of sarcopenia
2. Identify key macronutrients on building lean mass and calculations based on the patients’ goals
3. Prescribe key pharmaceutical approaches on increasing lean mass and improving body composition
4. Identify which exercise interventions are optimal for improving lean mass
---
Brief Biography
Dr. Alice Nguyen serves as the Director of Naturopathic Medicine at Stark Health, a position she has held for over eight years. In this role, she oversees the clinical operations of the department while training and mentoring naturopathic residents. Dr. Alice specializes in cardiometabolic medicine, hormone replacement therapy, and the management of autoimmune diseases, blending evidence-informed naturopathic treatments with cutting-edge clinical research.
Before embarking on her career in naturopathic medicine, Dr. Alice was a Master Instructor at Equinox in Santa Monica, drawing on her extensive experience in the fitness industry, where she has worked for 16 years. She holds a 3rd-degree black belt in both karate and traditional Japanese jujutsu, which shapes her holistic approach to health and wellness. Her passion for optimizing human performance drives her commitment to patient care and professional education.
Ahmed El-Sohemy
PART 1
Nutrition, Genetics and Premenstrual Symptoms
Around 80-90% of women experience premenstrual symptoms during reproductive age, affecting millions of women around the world. Such symptoms are dual in nature, appearing as either somatic, such as breast pain, acne, and abdominal cramps, or psychological, such as mood swings, depression, and anxiety. Some symptoms can severely affect the quality of life for women by impacting work and school absenteeism, as well as affecting social and interpersonal relationships. There is growing evidence that both nutrition and genetics play a role in the risk and severity of premenstrual symptoms. Our research over the past 10 years has uncovered several micronutrients that can affect the risk and severity of developing specific premenstrual symptoms. Moreover, we have also shown that common genetic variations can explain why some women are impacted more than others by specific dietary factors. This presentation will cover both published findings and recent cutting-edge research that has not yet been published showing up to a 5-fold increase in risk of certain premenstrual symptoms depending on both diet and genotype. This emerging field of women’s health may lead to the development of precision nutrition strategies to reduce the incidence and severity of premenstrual symptoms.
After the presentation, participants will be able to confidently:
1. Learn what the most common premenstrual symptoms are.
2. Understand which dietary factors are associated with premenstrual symptoms.
3. Learn which genetic markers to test for to determine who benefits from which interventions.
PART 2
Precision Nutrition: Recent Advances and Controversies in Genetic Testing
There is increasing awareness among researchers, educators, healthcare professionals and consumers that the one-size-fits-all, population-based approach to nutritional guidance is inefficient and sometimes ineffective. Genetic differences can explain individual differences in response to various dietary factors and randomized controlled trials show that DNA-based dietary recommendations can improve compliance. With increasing awareness and demand for genetic testing, there is a need for healthcare professionals to have sufficient knowledge to understand and determine the benefits and limitations of the science and testing.
After the presentation, participants will be able to confidently
1. Understand how genetic variation impacts nutritional requirements.
2. Learn how to identify relevant genetic markers with clinical relevance.
3. Recognize the benefits and limitations of consumer genetic testing and understand what genetic tests can and cannot reveal about a person’s health and dietary recommendations.
Terry Manning II ND, RMSK, MA
PART 1
The regenerative properties of adipose tissue and how these can be harnessed for MSK conditions
Regenerative medicine is reshaping the landscape of modern healthcare, with its application in musculoskeletal (MSK) conditions emerging as a leader in evidence-based innovation. Among these therapies, microfragmented adipose tissue (MFAT), derived from a patient’s own fat, stands out as a uniquely effective solution. Boasting exceptional regenerative properties, MFAT has become the preferred choice for treating tendon and ligament injuries, offering natural and transformative outcomes. This session will delve into the science behind adipose tissue, the step-by-step processes for acquiring and processing it, clinical indications for its use, and compelling case studies that highlight its real-world success.
Goals and Objectives:
Identify patients most likely to benefit from adipose tissue-based therapies.
Master the techniques for acquiring and preparing adipose tissue for MSK applications.
Differentiate between various autologous regenerative medicine options to make evidence-based treatment decisions.
---
PART 2
Regenerative medicine for orthopedic complaints: good candidates and successful outcomes
Regenerative medicine holds immense potential, but it is grounded in science—not magic. Unfortunately, the rapid growth of illegitimate practices has created confusion among patients and referring providers, muddying the waters of this innovative field. As with any medical treatment, proper patient selection is the cornerstone of achieving successful outcomes. This presentation will focus on the evidence supporting regenerative medicine in treating common musculoskeletal (MSK) conditions and provide practical guidance for primary care providers.
Attendees will learn to identify the patients and diagnoses most suited for referral to a regenerative medicine specialist, ensuring optimal care. Additionally, this presentation will empower primary care providers with the tools to recognize reputable regenerative medicine experts, helping them navigate the complexities of this growing field and confidently guide their patients toward evidence-based treatments.
Goals and Objectives:
1. Identify patients that are good candidates for regenerative medicine
2. Discern reputable regenerative medicine practitioners to refer patients.
3. Treat specific MSK conditions with regenerative medicine.
4. Differentiate the ethical and unethical implementation of regenerative medicine.
5. Help prepare their patients and optimize outcomes of regenerative medicine procedures.
Biography:
Terry Manning II, ND, RMSK is a regenerative medicine specialist practicing in Lake Oswego, OR focusing on non-surgical treatment of spine and musculoskeletal conditions. Dr. Manning completed a 3-year residency, specifically in the field of interventional orthobiologics under the supervision of visionaries and thought leaders within the field. He has been in practice for nearly a decade.
Dr. Manning is recognized internationally for his expertise in diagnostic and interventional musculoskeletal ultrasound and serves as a subject matter expert in the field. Dr. Manning is president of the Naturopathic Orthopedic Medicine Academy, board member of the Oregon Association of Naturopathic Medicine, member of the Interventional Orthobiologics Foundation, and serves on the Oregon Pain Management Commission. Dr. Manning is a sought-after presenter and enjoys sharing his passion for regenerative medicine to other professionals. From professional athletes to weekend warriors or those with persistent pain, Dr. Manning delivers individualized care and exceptional outcomes. In addition to his clinical practice, Dr. Manning teaches at the National University of Natural Medicine, and trains and consults other providers at regenmskconsult.com. He and his wife, Dr. Val Manning, have 2 daughters and love to take advantage of all that the PNW has to offer.
